Aboca names Jan Linnemann to lead German phytotherapy expansion

Aboca, an Italian producer of natural health solutions, has appointed Jan Linnemann as its new head of German operations. The company, which has steadily grown its presence in Germany since 2016, now aims to strengthen its position in the phytotherapy market.

Linnemann took on the role of Country Manager for Germany in mid-January, bringing extensive experience from senior positions in the pharmaceutical sector.

Aboca was established in 1978 in a small Tuscan town. The family-owned business now employs around 1,800 people and manages 1,200 hectares of land for cultivating about 70 medicinal plants. All research, development, and production stages remain in-house, ensuring full control over product quality.

The company entered the German market in October 2016 with its subsidiary, Aboca Deutschland GmbH. Since then, annual sales have grown by roughly 15-20% on average, driven by wider distribution and new partnerships. While exact revenue figures are not disclosed, the firm has expanded from natural health products to a broader focus on phytotherapy.

Linnemann arrives with a strong background in pharmaceutical leadership. He spent over 14 years at Medice in senior management before working as an independent consultant. Most recently, he served as the fourth managing director at Quiris, where he oversaw marketing and sales.

At Aboca, he will lead the company's German expansion, building on its existing portfolio of twelve brands. The firm's integrated approach—from cultivation to final product—sets it apart in the natural health sector.

Linnemann's appointment comes as Aboca continues its growth in Germany. The company's focus on in-house production and natural ingredients aligns with rising demand for phytotherapy solutions. With a stronger market position planned by 2025, Aboca aims to further increase its reach under his leadership.